Nitric oxide and BCNU chemoresistance in C6 glioma cells: Role of S-nitrosoglutathione

Free Radical Biology and Medicine

Volumn 36, Issue 10, 2004, Pages 1317-1328

  Yang, Ding I ^a,b   Yin, Jiu Haw ^b,c   Ju, Tzyh Chwen ^a   Chen, Long Shiuh ^d   Hsu, Chung Y ^b,e  

^a TZU CHI UNIVERSITY   (Taiwan)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TAO YUAN GENERAL HOSPITAL   (Taiwan)

^d Medinox Inc   (United States)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

1,3 bis(2 chloroethyl) 1 nitrosourea; Alkylation; BCNU; BSO; Buthionine sulfoximine; Carbamoylation; CCNU; Free radicals; Inducible nitric oxide synthase; Malignant glioblastoma multiforme; N Acetyl L cysteine; Nitric oxide; S Nitrosoglutathione; S Nitrosothiol

Indexed keywords

2,9 DIMETHYL 1,10 PHENANTHROLINE; CARMUSTINE; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE DONOR; S NITROSOGLUTATHIONE;

ALKYLATION; ANTIOXIDANT ACTIVITY; ARTICLE; CARBAMOYLATION; CELL PROTECTION; CHELATION; CHEMOSENSITIVITY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG CYTOTOXICITY; DRUG POTENCY; GLIOMA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ALKYLATION; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTIOXIDANTS; CARBAMATES; CARMUSTINE; CHELATING AGENTS; DRUG RESISTANCE, NEOPLASM; GLIOMA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHENANTHROLINES; RATS; S-NITROSOGLUTATHIONE; TUMOR CELLS, CULTURED;

EID: 1942532041     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.02.010     Document Type: Article

References (63)

1. Kleihues P., Soylemezoglu F., Schauble B., Scheithauer B.W., Burger P.C. Histopathology, classification and grading of gliomas. Glia. 15:1995;211-221.
2. Rajkumar S.V., Buckner J.C., Schomberg P.J., Pitot H.C.T., Ingle J.N., Cascino T.L. Phase I evaluation of pre-irradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas. Neurosurgery. 44:1999;67-73.
3. Paoletti P. Therapeutic strategy for central nervous system tumors: present status, criticism and potential. J. Neurosurg. Sci. 28:1984;51-60.
4. Fine H.A., Dear K.B., Loeffler J.S., Black P.M., Canellos G.P. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 71:1993;2585-2597.
5. Green S.B., Byar D.P., Walker M.D., Pistenmaa D.A., Alexander E.J., Batzdorf U., Brooks W.H., Hunt W.E., Mealey J.J., Odom G.L., Paoletti P., Ransohoff J.D., Robertson J.T., Selker R.G., Shapiro W.R., Smith K.R.J., Wilson C.B., Strike T.A. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat. Rep. 67:1983;121-132.
6. Walker M.D., Green S.B., Byar D.P., Alexander E.J., Batzdorf U., Brooks W.H., Hunt W.E., MacCarty C.S., Mahaley M.S.J., Mealey J.J., Owens G., Ransohoff J.d., Robertson J.T., Shapiro W.R., Smith K.R.J., Wilson C.B., Strike T.A. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N. Engl. J. Med. 303:1980;1323-1329.
7. Nutt C.L., Noble M., Chambers A.F., Cairncross J.G. Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Res. 60:2000;4812-4818.
8. Rolhion C., Penault-Llorca F., Kemeny J.L., Kwiatkowski F., Lemaire J.J., Chollet P., Finat-Duclos F., Verrelle P. O(6)-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation. Int. J. Cancer. 84:1999;416-420.
9. Ali-Osman F., Stein D.E., Renwick A. Glutathione content and glutathione-S-transferase expression in 1,3-bis(2-chloroethyl)-1-nitrosourea- resistant human malignant astrocytoma cell lines. Cancer Res. 50:1990;6976-6980.
10. Xie Q.W., Cho H.J., Calaycay J., Mumford R.A., Swiderek K.M., Lee T.D., Ding A., Troso T., Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 256:1992;225-228.
11. Fujisawa H., Ogura T., Hokari A., Weisz A., Yamashita J., Esumi H. Inducible nitric oxide synthase in a human glioblastoma cell line. J. Neurochem. 64:1995;85-91.
12. Hara E., Takahashi K., Tominaga T., Kumabe T., Kayama T., Suzuki H., Fujita H., Yoshimoto T., Shirato K., Shibahara S. Expression of heme oxygenase and inducible nitric oxide synthase mRNA in human brain tumors. Biochem. Biophys. Res. Commun. 224:1996;153-158.
13. Ellie E., Loiseau H., Lafond F., Arsaut J., Demotes-Mainard J. Differential expression of inducible nitric oxide synthase mRNA in human brain tumours. NeuroReport. 7:1995;294-296.
14. Chiueh C.C., Rauhala P. The redox pathway of S-nitrosoglutathione, glutathione and nitric oxide in cell to neuron communications. Free Radic. Res. 31:1999;641-650.
15. Rauhala P., Lin A.M., Chiueh C.C. Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J. 12:1998;165-173.
16. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
17. Wheeler G.P., Bowdon B.J., Grimsley J.A., Lloyd H.H. Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas. Cancer Res. 34:1974;194-200.
18. Yin J.H., Yang D.I., Chou H., Thompson E.M., Xu J., Hsu C.Y. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in C6 glioma cells. J. Pharmacol. Exp. Ther. 297:2001;308-315.
19. Shyam K., Penketh P.G., Loomis R.H., Rose W.C., Sartorelli A.C. Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-hydrazines. J. Med. Chem. 39:1996;796-801.
20. Penketh P.G., Shyam K., Sartorelli A.C. Comparison of DNA lesions produced by tumor-inhibitory 1,2-bis(sulfonyl)hydrazines and chloroethylnitrosoureas. Biochem. Pharmacol. 59:2000;283-291.
21. Yin J.H., Yang D.I., Ku G., Hsu C.Y. iNOS expression inhibits hypoxia-inducible factor-1 activity. Biochem. Biophys. Res. Commun. 279:2000;30-34.
22. Tsikas D., Sandmann J., Ikic M., Fauler J., Stichtenoth D.O., Frolich J.C. Analysis of cysteine and N-acetylcysteine in human plasma by high-performance liquid chromatography at the basal state and after oral administration of N-acetylcysteine. J. Chromatogr. B Biomed. Sci. Appl. 708:1998;55-60.
23. Xu J., Yeh C.-H., Chen S., He L., Sense S.L., Canzoniero L.M.T., Choi D.W., Hsu C.Y. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-α/cycloheximide-induced cerebral endothelial cell death. J. Biol. Chem. 273:1998;16521-16526.
24. Stubauer G., Giuffre A., Sarti P. Mechanism of S-nitrosothiol formation and degradation mediated by copper ions. J. Biol. Chem. 274:1999;28128-28133.
25. Anderson M.E., Meister A. Transport and direct utilization of gamma-glutamylcyst(e)ine for glutathione synthesis. Proc. Natl. Acad. Sci. USA. 80:1983;707-711.
26. Singh I., Pahan K., Khan M., Singh A.K. Cytokine-mediated induction of ceramide production is redox-sensitive: implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J. Biol. Chem. 273:1998;20354-20362.
27. Hirrlinger J., Konig J., Keppler D., Lindenau J., Schulz J.B., Dringen R. The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress. J. Neurochem. 76:2001;627-636.
28. Hirrlinger J., Schulz J.B., Dringen R. Glutathione release from cultured brain cells: multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells. J. Neurosci. Res. 69:2002;318-326.
29. Gordge M.P., Meyer D.J., Hothersall J., Neild G.H., Payne N.N., Noronha-Dutra A. Copper chelation-induced reduction of the biological activity of S-nitrosothiols. Br. J. Pharmacol. 114:1995;1083-1089.
30. Gorren A.C., Schrammel A., Schmidt K., Mayer B. Decomposition of S-nitrosoglutathione in the presence of copper ions and glutathione. Arch. Biochem. Biophys. 330:1996;219-228.
31. Al-Sa'doni H.H., Megson I.L., Bisland S., Butler A.R., Flitney F.W. Neocuproine, a selective Cu(I) chelator, and the relaxation of rat vascular smooth muscle by S-nitrosothiols. Br. J. Pharmacol. 121:1997;1047-1050.
32. Pfeiffer S., Schrammel A., Schmidt K., Mayer B. Electrochemical determination of S-nitrosothiols with a Clark-type nitric oxide electrode. Anal. Biochem. 258:1998;68-73.
33. Schrammel A., Pfeiffer S., Schmidt K., Koesling D., Mayer B. Activation of soluble guanylyl cyclase by the nitrovasodilator 3-morpholinosydnonimine involves formation of S-nitrosoglutathione. Mol. Pharmacol. 54:1998;207-212.
34. De Man J.G., Moreels T.G., De Winter B.Y., Herman A.G., Pelckmans P.A. Neocuproine potentiates the activity of the nitrergic neurotransmitter but inhibits that of S-nitrosothiols. Eur. J. Pharmacol. 381:1999;151-159.
35. Gocmen C., Gokturk H.S., Ertug P.U., Onder S., Dikmen A., Baysal F. Effect of neocuproine, a selective Cu(I) chelator, on nitrergic relaxations in the mouse corpus cavernosum. Eur. J. Pharmacol. 406:2000;293-300.
36. De Man J.G., Moreels T.G., De Winter B.Y., Herman A.G., Pelckmans P.A. Pre- and postjunctional protective effect of neocuproine on the nitrergic neurotransmitter in the mouse gastric fundus. Br. J. Pharmacol. 132:2001;277-285.
37. Romeo A.A., Capobianco J.A., English A.M. Heme nitrosylation of deoxyhemoglobin by S-nitrosoglutathione requires copper. J. Biol. Chem. 277:2002;24135-24141.
38. Troy C.M., Rabacchi S.A., Friedman W.J., Frappier T.F., Brown K., Shelanski M.L. Caspase-2 mediates neuronal cell death induced by beta-amyloid. J. Neurosci. 20:2000;1386-1392.
39. Sporbert A., Mertsch K., Smolenski A., Haseloff R.F., Schonfelder G., Paul M., Ruth P., Walter U., Blasig I.E. Phosphorylation of vasodilator- stimulated phosphoprotein: a consequence of nitric oxide- and cGMP-mediated signal transduction in brain capillary endothelial cells and astrocytes. Brain Res. Mol. Brain Res. 67:1999;258-266.
40. Rauhala P., Mohanakumar K.P., Sziraki I., Lin A.M., Chiueh C.C. S-nitrosothiols and nitric oxide, but not sodium nitroprusside, protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo. Synapse. 23:1996;58-60.
41. Rauhala P., Lin A.M., Chiueh C.C. Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J. 12:1998;165-173.
42. 2-mediated nitric oxide release from S-nitrosoglutathione: role of glutamate. Arch. Biochem. Biophys. 372:1999;8-15.
43. Kilbourn R.G., Szabo C., Traber D.L. Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock. 7:1997;235-246.
44. Sheu F.S., Zhu W., Fung P.C. Direct observation of trapping and release of nitric oxide by glutathione and cysteine with electron paramagnetic resonance spectroscopy. Biophys. J. 78:2000;1216-1226.
45. Bartberger M.D., Liu W., Ford E., Miranda K.M., Switzer C., Fukuto J.M., Farmer P.J., Wink D.A., Houk K.N. The reduction potential of nitric oxide (NO) and its importance to NO biochemistry. Proc. Natl. Acad. Sci. USA. 99:2002;10958-10963.
46. Wink D.A., Cook J.A., Pacelli R., DeGraff W., Gamson J., Liebmann J., Krishna M.C., Mitchell J.B. The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: a direct correlation between nitric oxide formation and protection. Arch. Biochem. Biophys. 331:1996;241-248.
47. Rosenberg P.A., Li Y., Ali S., Altiok N., Back S.A., Volpe J.J. Intracellular redox state determines whether nitric oxide is toxic or protective to rat oligodendrocytes in culture. J. Neurochem. 73:1999;476-484.
48. Tew K.D., Kyle G., Johnson A., Wang A.L. Carbamoylation of glutathione reductase and changes in cellular and chromosome morphology in a rat cell line resistant to nitrogen mustards but collaterally sensitive to nitrosoureas. Cancer Res. 45:1985;2326-2333.
49. Jochheim C.M., Baillie T.A. Selective and irreversible inhibition of glutathione reductase in vitro by carbamate thioester conjugates of methyl isocyanate. Biochem. Pharmacol. 47:1994;1197-1206.
50. Vanhoefer U., Yin M.B., Harstrick A., Seeber S., Rustum Y.M. Carbamoylation of glutathione reductase by N,N-bis(2-chloroethyl)-N-nitrosourea associated with inhibition of multidrug resistance protein (MRP) function. Biochem. Pharmacol. 53:1997;801-809.
51. Ma X.L., Gao F., Liu G.L., Lopez B.L., Christopher T.A., Fukuto J.M., Wink D.A., Feelisch M. Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. Proc. Natl. Acad. Sci. USA. 96:1999;14617-14622.
52. Wink D.A., Feelisch M., Fukuto J., Chistodoulou D., Jourd'heuil D., Grisham M.B., Vodovotz Y., Cook J.A., Krishna M., DeGraff W.G., Kim S., Gamson J., Mitchell J.B. The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO. Arch. Biochem. Biophys. 351:1998;66-74.
53. Nelli S., Hillen M., Buyukafsar K., Martin W. Oxidation of nitroxyl anion to nitric oxide by copper ions. Br. J. Pharmacol. 131:2000;356-362.
54. Nelli S., McIntosh L., Martin W. Role of copper ions and cytochrome P450 in the vasodilator actions of the nitroxyl anion generator, Angeli's salt, on rat aorta. Eur. J. Pharmacol. 412:2001;281-289.
55. Borutaite V., Budriunaite A., Brown G.C. Reversal of nitric oxide-, peroxynitrite- and S-nitrosothiol-induced inhibition of mitochondrial respiration or complex I activity by light and thiols. Biochim. Biophys. Acta. 1459:2000;405-412.
56. Chiueh C.C. S-Nitrosoglutathione (GSNO) mediates brain response to hypoxia. Pediatr. Res. 51:2002;414.
57. Lipton A.J., Johnson M.A., Macdonald T., Lieberman M.W., Gozal D., Gaston B. S-nitrosothiols signal the ventilatory response to hypoxia. Nature. 413:2001;171-174.
58. Salt T.E., Zhang H., Mayer B., Benz B., Binns K.E., Do K.Q. Novel mode of nitric oxide neurotransmission mediated via S-nitroso-cysteinyl-glycine. Eur. J. Neurosci. 12:2000;3919-3925.
59. Hogg N., Singh R.J., Konorev E., Joseph J., Kalyanaraman B. S-nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase. Biochem. J. 323:1997;477-481.
60. Swaroop G.R., Malcolm G.P., Kelly P.A.T., Ritchie I., Whittle I.R. Effects of nitric oxide modulation on tumour blood flow and microvascular permeability in C6 glioma. NeuroReport. 9:1998;2577-2581.
61. Friedman H.S., McLendon R.E., Kerby T., Dugan M., Bigner S.H., Henry A.J., Ashley D.M., Krischer J., Lovell S., Rasheed K., Marchev F., Seman A.J., Cokgor I., Rich J., Stewart E., Colvin O.M., Provenzale J.M., Bigner D.D., Haglund M.M., Friedman A.H., Modrich P.L. DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J. Clin. Oncol. 16:1998;3851-3857.
62. Sanderson R.J., Mosbaugh D.W. Fidelity and mutational specificity of uracil-initiated base excision DNA repair synthesis in human glioblastoma cell extracts. J. Biol. Chem. 273:1998;24822-24831.
63. Lassen L.H., Ashina M., Christiansen I., Ulrich V., Olesen J. Nitric oxide synthase inhibition in migraine (letter). Lancet. 349:1997;401-402.